IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lyra Therapeutics Inc (LYRA)

CUSIP: 55234L204 | NYSE | Healthcare · Biotechnology | Micro Cap | 38 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/APerceptive Advisors LLC00.0%Fell below 5%Nov 21, 2025229,382 sh (Sep 30, 2025)
13D/APerceptive Advisors LLC

Institutional Holders — Q1 2026

Sabby Management, LLC104,059
0.1% of portfolio›$51.1K
StyleTurnoverLocationFiled
Sabby Management, LLC
104,059$51.1K0.1%GrowthVery HighMiami Beach, FL2026-05-15
0
0.0% of class · Nov 21, 2025Fell below 5%
229,382 sh (Sep 30, 2025)